Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health Catalyst (HCAT) Operating Leases (2018 - 2026)

Health Catalyst filings provide 9 years of Operating Leases readings, the most recent being $13.5 million for Q1 2026.

  • On a quarterly basis, Operating Leases fell 14.41% to $13.5 million in Q1 2026 year-over-year; TTM through Mar 2026 was $13.5 million, a 14.41% decrease, with the full-year FY2025 number at $14.2 million, down 28.62% from a year prior.
  • Operating Leases hit $13.5 million in Q1 2026 for Health Catalyst, down from $14.2 million in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $21.0 million in Q4 2023 to a low of $13.5 million in Q1 2026.
  • Median Operating Leases over the past 5 years was $17.4 million (2023), compared with a mean of $17.3 million.
  • Biggest five-year swings in Operating Leases: grew 16.75% in 2023 and later decreased 28.62% in 2025.
  • Health Catalyst's Operating Leases stood at $18.0 million in 2022, then increased by 16.75% to $21.0 million in 2023, then fell by 5.37% to $19.9 million in 2024, then decreased by 28.62% to $14.2 million in 2025, then fell by 5.11% to $13.5 million in 2026.
  • The last three reported values for Operating Leases were $13.5 million (Q1 2026), $14.2 million (Q4 2025), and $15.1 million (Q3 2025) per Business Quant data.